
Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …

GlaxoSmithKline is being investigated by authorities in China in what appear to be two separate probes into the UK manufacturer’s …

From 1 July new pharmaceutical distributors in China will be obliged to adhere to the country’s recently-issued Good Supply Practice …

GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …
Boehringer Ingelheim has said it intends to construct a cell-culture biopharmaceutical production facility in China offering contract R&D and manufacturing …
China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …

Merck is to open a new manufacturing facility in Hangzhou, two decades after the company built its first plant in …

China’s State Food and Drug Administration (SFDA) has published a list of 28 excipients which are considered high-risk and therefore …
Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …

Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …
Switzerland has become the first country to be classed as having equivalent standards for the manufacture of active pharmaceutical ingredients …

The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …

Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …